← Back to Search

Cancer Vaccine

HPV vaccination for Human Papillomavirus Vaccination

N/A
Recruiting
Led By Isabel Scarinci, PhD
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
High school students enrolled in the Health Science Program at the Chambers County School District, Alabama
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year
Awards & highlights

Study Summary

This trial aims to increase HPV vaccination rates in Alabama, which are currently low compared to national goals. The plan is to involve high school students in promoting HPV vaccination through a multi-channel communication campaign, with

Who is the study for?
This trial is for the community of Chambers County, Alabama. It aims to increase HPV vaccination rates among children and adults aged 9 to 26. The focus is on a participatory campaign led by high school students with support from various organizations.Check my eligibility
What is being tested?
A multi-channel communication campaign called OPERATION WIPE OUT is being tested to boost HPV vaccine uptake in rural areas with high cervical cancer rates. High school students will lead the effort, linked to school-based vaccinations.See study design
What are the potential side effects?
Since this trial focuses on a communication campaign rather than a medical intervention, there are no direct side effects like those associated with drugs or medical procedures.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HPV Vaccination at the county level
Secondary outcome measures
HPV vaccination at the school level
Other outcome measures
Knowledge and confidence among the high school students

Trial Design

1Treatment groups
Experimental Treatment
Group I: HPV vaccinationExperimental Treatment1 Intervention
Multi-channel campaign to promote HPV vaccination

Find a Location

Who is running the clinical trial?

University of Alabama at BirminghamLead Sponsor
1,590 Previous Clinical Trials
2,281,633 Total Patients Enrolled
Isabel Scarinci, PhDPrincipal InvestigatorUniversity of Alabama at Birmingham

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the necessary criteria to participate in this medical study?

"Candidates seeking entry into this trial must have received the human papillomavirus vaccine and fall within the age range of 15 to 18 years. The study aims to recruit a total of 29 participants."

Answered by AI

Are there any vacancies available for patients to participate in this trial?

"The ongoing search for suitable candidates is documented on clinicaltrials.gov. The trial's initial posting was recorded on October 29th, 2023 and the latest update occurred on January 30th, 2024."

Answered by AI

Is there an age limit regarding patient eligibility for this medical study, specifically for individuals under 40 years old?

"Subjects aged between 15 and 18 years are eligible for enrollment based on the specified age parameters in this research study."

Answered by AI

What is the current number of participants involved in this clinical investigation?

"Affirmative. Records from clinicaltrials.gov demonstrate that the ongoing medical trial is actively seeking participants. Initially shared on October 29, 2023, and most recently revised on January 30, 2024, this study aims to recruit a total of 29 patients across one designated site."

Answered by AI
~11 spots leftby Jul 2024